FTC Probes Express Scripts Deal for Market Fairness
Published Date: 2/12/2026
Notice
Summary
The Federal Trade Commission is reviewing a deal with Express Scripts and others to stop unfair business practices. This affects healthcare companies and could change how they compete, aiming for a fairer market. People have until March 16, 2026, to share their thoughts before the deal is final.
Analyzed Economic Effects
9 provisions identified: 8 benefits, 0 costs, 1 mixed.
Caps member costs to a drug's net price
If a plan sponsor adopts Express Scripts' required "standard offering," members' out-of-pocket costs for drugs must be no higher than the drug's net cost and cannot be tied to a higher list price. The Proposed Order requires this protection in the standard offering and says Cigna's fully‑insured health plans must adopt the same protections.
Cigna fully‑insured plans must adopt protections
All of Cigna's fully‑insured health plans are required by the Proposed Order to adopt the patient cost protections that limit member out-of-pocket costs to no more than a drug's net cost.
Pass rebates to members at point of sale; ban spread pricing
Under the standard offering, ESI must enable members to receive the benefit of any rebate or discount at the pharmacy point of sale (without charging a fee beyond actual pre‑funding costs), may not provide plan sponsors with rebate guarantees, and may not use spread pricing where the PBM charges a different amount than it reimburses pharmacies.
Pay small retail pharmacies actual cost plus fee
ESI must offer a standard contract to retail community pharmacies (businesses with three or fewer retail stores) that compensates them based on their actual drug acquisition cost plus a dispensing fee, pays extra for non‑dispensing services, and does not exclude any retail community pharmacy willing to accept the terms.
Insulin Patient Assurance Program access
If a plan sponsor adopts a formulary that includes an insulin product covered by ESI's Patient Assurance Program, ESI must provide full access to that Program for all members unless the plan sponsor opts out in writing, offering extra protection against high out‑of‑pocket insulin costs.
Require low‑WAC drug versions on formularies
ESI must place low‑WAC (lower list‑price) versions of drugs on its four standard commercial formularies without disadvantaging them compared to high‑WAC versions, except when the low‑WAC version is higher net cost or unavailable in sufficient supply. The change is intended to address situations where list‑price choices increased patients' out‑of‑pocket costs.
Require annual drug cost and claims transparency
ESI must provide plan sponsors as part of its standard offering an annual report showing each drug's costs, pharmacy claim‑level reporting, and any compensation paid to consultants or brokers related to pharmacy benefit services.
Delink manufacturer pay from list price
For ESI's standard offering, compensation from drug manufacturers to ESI may not be based, directly or indirectly, on a drug's list price (WAC). The change is intended to remove incentives tied to higher list prices.
Reshore ESI's group purchasing organization
The Proposed Order requires ESI to move its group purchasing organization (GPO) Ascent from Switzerland to the United States.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-16827, Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
The Federal Trade Commission (FTC or Commission) requests that the Office of Management and Budget (OMB) extend for three years the current Paperwork Reduction Act (PRA) clearance for its Trade Regulation Rule on Disclosure Requirements and Prohibitions Concerning Franchising (Franchise Rule or Rule). The current clearance expires on August 31, 2026.
2026-16617, Regulatory Agenda
The Federal Trade Commission (FTC or Commission) is publishing its regulatory agenda in accordance with section 22(d)(1) of the Federal Trade Commission Act, 15 U.S.C. 57b-3(d)(1) and the Regulatory Flexibility Act (RFA), 5 U.S.C. 601 to 612, as amended by the Small Business Regulatory Enforcement Fairness Act. The Commission's agenda follows guidelines and procedures issued September 15, 2025, by the Office of Management and Budget in accordance with the provisions of Executive Order 12866, "Regulatory Planning and Review," 58 FR 51735 (Oct. 4, 1993) and Executive Order 14192, "Unleashing Prosperity Through Deregulation," 90 FR 9065 (Feb. 6, 2025). The Government-wide Unified Agenda of Federal Regulatory and Deregulatory Actions includes a list of all regulatory actions under development or review and is scheduled for publication in its entirety on www.reginfo.gov and www.regulations.gov in a format that offers users a greatly enhanced ability to obtain information from the agenda database. The RFA requires publication in the Federal Register of agenda entries for rules that are likely to have a significant impact on a substantial number of small entities (5 U.S.C. 602) and any such rules that the agency has identified for periodic review under section 610 of the RFA. For the 2026 agenda, the Commission has no rule that meets the RFA's publication requirements. The Commission has identified rulemakings that are likely to have some impact on small entities, but do not meet the RFA's publication requirements. The current rulemakings that are likely to have some impact on small entities are: (1) the Energy Labeling Rule, 16 CFR 305; (2) the Alternative Fuel Rule, 16 CFR 309; (3) the removal of the vacated 2024 amendments to the Negative Option Rule, 16 CFR 425; (4) the Cooling-Off Rule, 16 CFR 429; (5) the Amplifier Rule, 16 CFR 432; (6) the Business Opportunity Rule, 16 CFR 437; (7) the Impersonation Rule, 16 CFR 461; (8) the withdrawal of the final rule for the vacated Combating Auto Retail Scams Rule (16 CFR 463); (9) the proposed Earnings Claims Trade Regulation Rule, to be codified at 16 CFR 462; (10) Unfair or Deceptive Fees Trade Regulation Rule, 16 CFR 464; and (11) the removal of the vacated Non-Compete Clause Rule from 16 CFR 910. The Commission's rulemaking review process carefully considers regulatory burdens and streamlines rules when feasible and appropriate. The majority of the rulemakings listed in the agenda are being conducted as part of the Commission's systematic review of all of its regulations and guides on a rotating basis. Under the Commission's program, rules are reviewed on a 10-year schedule. In each rule review, the Commission requests public comments on, among other things, the economic impact and benefits of the rule; possible conflict between the rule and state, local, or other federal laws or regulations; and the effect on the rule of any technological, economic, or other industry changes. These reviews incorporate and expand upon the review required by the RFA and regulatory reform initiatives directing agencies to conduct a review of all regulations and eliminate or revise those that are outdated or otherwise in need of reform. Except for notice of completed actions, the information in this agenda represents the judgment of Commission staff, based upon information now available. Each projected date of action reflects FTC staff's assessment that the specified event will occur this year. No final determination by the staff or the Commission respecting the need for or the substance of a rule should be inferred from the notation of projected events in this agenda. In most instances, the dates of future events are listed by month, not by a specific day. The information in this agenda may change as new information, changes of circumstances, or changes in the law occur.
2026-15955, Privacy Act of 1974; System of Records
The FTC proposes to modify its Privacy Act system of records notices (SORNs) by adding a routine use to four specific SORNs to comply with Executive Order 14249, Protecting America's Bank Account Against Fraud, Waste, and Abuse, and OMB Memorandum M-25-32, Preventing Improper Payments and Protecting Privacy Through Do Not Pay. The FTC is also separately making technical changes to three of these SORNs.
2026-15913, Caremark and Zinc Health Services; Analysis of Proposed Agreement Containing Consent Order To Aid Public Comment
The consent agreement in this matter settles alleged violations of Federal law prohibiting unfair methods of competition. The attached Analysis of Proposed Agreement Containing Consent Orders to Aid Public Comment describes both the allegations in the complaint and the terms of the consent order--embodied in the consent agreement-- that would settle these allegations.
2026-15182, Petition for Rulemaking of the National Consumers League, Campaign for Fairer Gambling, the National Council for Problem Gambling, the Public Health Advocacy Institute, and Truth in Advertising, Inc.
Please take notice that the Federal Trade Commission ("Commission") received a petition for rulemaking from the National Consumers League, Campaign for Fairer Gambling, the National Council for Problem Gambling, the Public Health Advocacy Institute, and Truth in Advertising, Inc., and has published that petition online at https://www.regulations.gov. The Commission invites written comments concerning the petition. Publication of this petition is pursuant to the Commission's Rules of Practice and Procedure and does not affect the legal status of the petition or its final disposition.
2026-14920, Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
The Federal Trade Commission wants to keep its rules for how gas stations and fuel sellers measure and share fuel quality for three more years. This affects refiners, importers, distributors, and retailers who must keep records and share fuel ratings. Comments on this plan are open until September 21, 2026, and the paperwork costs about $455,000 a year in labor.
Previous / Next Documents
Previous: 2026-02840, Notice of OFAC Sanctions Actions
The U.S. Treasury’s OFAC updated the names on its sanctions lists to fix small errors and keep things clear. These changes affect people and groups already on the list, making sure the info is accurate and up-to-date. No new sanctions or money changes, just smarter records as of September 23, 2025.
Next: 2026-02846, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in March 2026 to review and evaluate grant applications related to health and science research. These meetings keep sensitive info private, protecting personal and trade secrets. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.